Advertisements



Flex Pharma Shares Plunge After Biotech Ends 2 Clinical Trials, Announces 60% Workforce Cut

Flex Pharma Inc (NASDAQ: FLKS) shares are slumping on above-average volume Wednesday following a release from the company announcing the scrapping of two clinical trials and the explo read more.....»»

Category: blogSource: benzingaJun 13th, 2018

Vaccinex Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

On-track to report topline data from CLASSICAL-Lung and SIGNAL clinical trials this year Announces expansion of pepinemab development program into Alzheimer's disease Completes private placement of c.....»»

Category: earningsSource: benzingaMar 9th, 2020

Inovio shares rally after biotech says human trials of coronavirus vaccine will start in April

Shares of Inovio Pharmaceuticals Inc. rallied more than 16% Tuesday, after the company said it’s accelerating the timeline for development of a vaccine to treat the coronavirus COVID-19 and expects to start human trials in the U.S. next month......»»

Category: topSource: marketwatchMar 3rd, 2020

Gilead announces more trials for drug aimed at COVID-19, stock up 4%

Shares of Gilead Sciences Inc. rose nearly 4% in th.....»»

Category: topSource: marketwatchFeb 26th, 2020

Nanocap Biotech Stock Rips 180% Higher On Coronavirus Drug Licensing

Cocrystal Pharma Inc (NASDAQ: COCP) shares are skyrocketing Monday following a licensing agreement the company reached with the Kansas State University Research Foundation. read more.....»»

Category: blogSource: benzingaFeb 24th, 2020

Foamix announces results from two pivotal Phase 3 clinical trials for FMX103

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 18th, 2020

Moleculin Biotech announces data from its CTCL clinical trial of WP1220

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 18th, 2020

The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»

Category: earningsSource: benzingaFeb 4th, 2020

Vertex Pharma stock rises on earnings, outlook beat

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

Category: topSource: marketwatchJan 30th, 2020

Pharma company gets $2.7M grant to continue "positive" Alzheimer"s treatment trials

Neurotrope announced the results of its latest confirmatory clinical trial......»»

Category: topSource: foxnewsJan 22nd, 2020

The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings

Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews of opioid pain drugs, a few clinical data readouts, presentations and updates at the JPMorgan Healthcare conference. Here are the key c.....»»

Category: earningsSource: benzingaJan 20th, 2020

What"s Driving The aTyr Pharma Rally?

Shares of the thinly traded nano-cap biotech aTyr Pharma Inc (NASDAQ: LIFE) were advancing strongly Monday on above-average volume. 0 read more.....»»

Category: blogSource: benzingaJan 6th, 2020

UPDATE: Spring Bank Pharma shares slide 45% premarket after it halts trial of treatment for hepatitis B virus

Spring Bank Pharmaceutical Inc.'s shares slid 45% in premarket trade Thursday, after the clinical-stage biopharma company said it has stopped dosing patients in a trial of a treatment for.....»»

Category: topSource: marketwatchDec 26th, 2019

Spring Bank Pharma shares slide 17% premarket after it halts trial of treatment for hepatitis B virus

Spring Bank Pharmaceutical Inc.'s shares slid 17% in premarket trade Thursday, after the clinical-stage biopharma company said it has stopped dosing patients in a trial of a treatment for.....»»

Category: topSource: marketwatchDec 26th, 2019

Allergan"s migraine drug approved by FDA

Shares of Allergan gained 0.5% after the Food and Drug Administration approved Ubrelvy, its migraine treatment. In two late-stage clinical trials, more patients who were taking the experimental therapy reported the pain ending within t.....»»

Category: topSource: marketwatchDec 23rd, 2019

Cincinnati Children’s strikes deal with pharma firms

Cincinnati Children’s Hospital has entered into an agreement to advance clinical development of a medicine that involves several pharmaceutical firms. Fortress Biotech Inc. disclosed today that Baergic Bio Inc., a newly formed Fortress partner .....»»

Category: topSource: bizjournalsDec 23rd, 2019

Mid-Day Market Update: Steelcase Surges On Upbeat Q3 Results; Aduro BioTech Shares Plunge

Midway through trading Wednesday, the Dow traded up 0.04% to 28277.07 while the NAS.....»»

Category: earningsSource: benzingaDec 18th, 2019

High Flying Biotech Axsome Skyrockets On Positive Late-Stage Results For Depression Drug

Shares of Axsome Therapeutics Inc (NASDAQ: AXSM), the best-performing biotech of the year, were ripping higher Monday following a positive clinical rea 0 read more.....»»

Category: blogSource: benzingaDec 16th, 2019

BeiGene announces data from two clinical trials of Brukinsa at ASH meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 8th, 2019

FSD Pharma Reports Third Quarter 2019 Financial Results

- Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20 – -Â.....»»

Category: earningsSource: benzingaNov 29th, 2019

Karuna Therapeutics Shares Rip Higher After Schizophrenia Drug Aces Midstage Trial

Shares of the thinly traded, small-cap biotech Karuna Therapeutics Inc (NASDAQ: KRTX) were moving higher Monday on a positive clinical trial readout. 0 read more.....»»

Category: blogSource: benzingaNov 18th, 2019